Jasbir Seehra
Vermogen: 5 M $ op 31-05-2026
Vermogen: 5 M $ op 31-05-2026
Jasbir S.
Seehra was the founder of Acceleron Pharma, Inc., founded in 2004, where the title held was Chief Scientific Officer & Senior Vice President from 2004 to 2010.
The current job is President, Chief Executive Officer & Director at Keros Therapeutics, Inc., starting in 2015 and continuing.
Former jobs include Independent Director at Eloxx Pharmaceuticals, Inc. from 2018 to 2022; Vice President at Wyeth LLC; Principal at Genetics Institute LLC; Principal at AVEO Pharmaceuticals, Inc.; Chief Scientific Officer at Ember Therapeutics, Inc. from 2011 to 2015; and Vice President-Biological Chemistry at Wyeth Pharmaceuticals, Inc. Education includes undergraduate and doctorate degrees from The University of Southampton.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-04-2026 | 440.708 ( 2,23% ) | 5 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Algemeen Directeur | 01-12-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 28-06-2022 |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Hoofd Techniek/Wetenschap/O&O | 01-04-2015 |
| ACCELERON PHARMA INC. | Oprichter | 01-11-2010 |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau